Contact
searchSearch
HMP Global

Peripheral Arterial Disease: Features

Dr Ramon Varcoe
ISET 2025
The Role of Bioresorbable Stents in Tibial Disease: When and Where?
03/26/2025
Ramon L. Varcoe, MBBS, MS, PhD
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his...
03/26/2025
Vascular Disease Management
Dr Jay Mathews
ISET 2025
DETOUR Patient Selection in Complex PAD: Expert Insights from Dr. Jay Mathews
03/24/2025
S. Jay Mathews, MD, MS, FACC, FSCAI
Dr. Jay Mathews breaks down the key clinical and anatomical factors in selecting the right patients for the DETOUR procedure in complex peripheral artery disease.
Dr. Jay Mathews breaks down the key clinical and anatomical factors in selecting the right patients for the DETOUR procedure in complex peripheral artery disease.
Dr. Jay Mathews breaks down the...
03/24/2025
Vascular Disease Management
Original Research
Endovascular Treatment of Peripheral Arterial Disease and Critical Limb-Threatening Ischemia Can Be Safely Performed With 4F Arterial Access
03/19/2025
Sreejit Nair, MD; Joseph Puma, DO; Justin A. Ratcliffe, MD; Ashwani Sastry, MD
This study evaluates the safety and feasibility of utilizing a 4F arterial access approach for treating PAD and CLTI in an outpatient setting.
This study evaluates the safety and feasibility of utilizing a 4F arterial access approach for treating PAD and CLTI in an outpatient setting.
This study evaluates the safety...
03/19/2025
Vascular Disease Management
Dr Daniel Clair
ISET 2025
First Clinical Use of a Novel Forward-Shifted Peripheral Intravascular Lithotripsy System: Primary Outcomes of the FORWARD IDE and Feasibility Studies
03/17/2025
Daniel G. Clair, MD
In this video, Dr Daniel Clair, discusses the key findings of the FORWARD PAD IDE trial and its feasability studies.
In this video, Dr Daniel Clair, discusses the key findings of the FORWARD PAD IDE trial and its feasability studies.
In this video, Dr Daniel Clair, ...
03/17/2025
Vascular Disease Management
Dr Marianne Brodmann
ISET 2025
1-Year Results From the RESOLV I Trial
03/14/2025
Marianne Brodmann, MD
In this video, Dr Brodmann provides an overview of her ISET 2025 presentation on the 1-year results of the RESOLV I trial.
In this video, Dr Brodmann provides an overview of her ISET 2025 presentation on the 1-year results of the RESOLV I trial.
In this video, Dr Brodmann...
03/14/2025
Vascular Disease Management
Dr John Rundback
ISET 2025
Maintaining a DVA
03/10/2025
John H. Rundback, MD, FAHA, FSIR
In this video, interventional radiologist John Rundback, MD, discusses his ISET 2025 presentation on Maintaining a DVA.
In this video, interventional radiologist John Rundback, MD, discusses his ISET 2025 presentation on Maintaining a DVA.
In this video, interventional...
03/10/2025
Vascular Disease Management
Interview
The Role of GLP-1 Drugs in the Treatment of PAD
03/04/2025
Ian Del Conde, MD, FACC, FSVM
At ISET 2025, Dr Ian Del Conde gave a presentation on GLP-1 receptor agonists, which show promise in improving cardiovascular disease.
At ISET 2025, Dr Ian Del Conde gave a presentation on GLP-1 receptor agonists, which show promise in improving cardiovascular disease.
At ISET 2025, Dr Ian Del Conde...
03/04/2025
Vascular Disease Management
Original Research
The Active Closure Registry
02/21/2025
Frank J. Arena, MD
In this research paper, the author describes techniques designed to minimize complications associated with nonradial access.
In this research paper, the author describes techniques designed to minimize complications associated with nonradial access.
In this research paper, the...
02/21/2025
Vascular Disease Management
Interview
Technical Advances in Deep Venous Arterialization With the LimFlow Device
02/12/2025
Anahita Dua, MD, MS, MBA, FACS
At VEITH 2024, Dr Anahita Dua gave a presentation entitled “Technical Advances in DVA With the LimFlow Device: Improved Access, Better Post Procedural Care, and Wound Management Are Essential.” VDM spoke with Dr Dua about her presentation.
At VEITH 2024, Dr Anahita Dua gave a presentation entitled “Technical Advances in DVA With the LimFlow Device: Improved Access, Better Post Procedural Care, and Wound Management Are Essential.” VDM spoke with Dr Dua about her presentation.
At VEITH 2024, Dr Anahita Dua...
02/12/2025
Vascular Disease Management
Dr Brodmann
ISET 2025
Current State of Paclitaxel Drug-Coated Balloons and Drug-Eluting Stents
02/04/2025
Marianne Brodmann, MD
Marianne Brodmann, MD, presented an in-depth review of drug-coated balloons and drug-eluting stents for treating peripheral arterial disease.
Marianne Brodmann, MD, presented an in-depth review of drug-coated balloons and drug-eluting stents for treating peripheral arterial disease.
Marianne Brodmann, MD, presented...
02/04/2025
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

VentiV Clinical Images
Thrombectomy
FDA Clears New Mechanical Thrombectomy System
03/31/2025
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the...
03/31/2025
Cath Lab Digest
Restenosis
Real-world Data Shows Cook’s Zilver PTX Leads to Lower Rates of In-stent Occlusion Than Boston Scientific’s Eluvia
03/27/2025
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook...
03/27/2025
Vascular Disease Management
TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
Embolotherapy
Instylla Completes Submission of Premarket Approval Application for Embrace™ Hydrogel Embolic System
03/11/2025
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025...
03/11/2025
Vascular Disease Management
Resistant Hypertension
Corcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant Hypertension
03/10/2025
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a...
03/10/2025
Cath Lab Digest
Company expansion
Reflow Medical Expands Global Reach With New European Subsidiary
03/06/2025
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a...
03/06/2025
Cath Lab Digest
SCAI
Survey Confirms Radiation and Orthopedic Health Hazards in Cardiac Catheterization Laboratories are ‘Unacceptable’
03/05/2025
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the...
03/05/2025
Cath Lab Digest
Shockwave Javelin Peripheral IVL Catheter, a novel intravascular lithotripsy (IVL) platform designed to modify calcium and cross extremely narrowed vessels in patients with peripheral artery disease (PAD).
IVL
Shockwave Medical Launches Novel Forward Intravascular Lithotripsy Platform in U.S. to Transform Treatment of Difficult-to-Cross Calcified Lesions
03/04/2025
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the...
03/04/2025
Cath Lab Digest
Acute Ischemic Stroke
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
03/03/2025
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the...
03/03/2025
Vascular Disease Management
TEVAR
Zenith Alpha Thoracic 2 Now Available in US; First Case Performed
03/03/2025
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2...
03/03/2025
Vascular Disease Management

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use